Request Sample Inquiry
Genetic Testing Market

Genetic Testing Market

Genetic Testing Market - Global Industry Assessment & Forecast

img
Healthcare
Number Of Pages # Pages:

214

Base Year:

2024

Date

Oct - 2024

Format:

PDF XLS PPT

Report Code:

VMR-3019

Segments Covered
  • By Test Type By Test Type Diagnostic Testing, Predictive and Presymptomatic Testing, Carrier Testing, Prenatal and Newborn Screening, Pharmacogenomic Testing, Other
  • By Technology By Technology Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Chromosomal Microarray, Fluorescence In Situ Hybridization (FISH), Sanger Sequencing
  • By Application By Application Oncology, Rare Diseases, Neurological Disorders, Cardiovascular Diseases, Genetic Disease Risk Assessment, Ancestry Testing, Paternity Testing, Other
  • By End-User By End-User Hospitals and Clinics, Diagnostic Laboratories, Research Institutes, Direct-to-Consumer (DTC) Testing Services, Forensic Laboratories, Other
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2024
Forecast YearsForecast Years: 2025 - 2034
Historical YearsHistorical Years: 2019 - 2023
Revenue 2024Revenue 2024: USD 22.60 Billion
Revenue 2034Revenue 2034: USD 65.91 Billion
Revenue CAGRRevenue CAGR (2025 - 2034): 11.3%
Fastest Growing Region Fastest Growing Region (2025 - 2034) Asia Pacific
Largest Region Largest Region (2024): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Genetic Testing Market - Segment Analysis
    1. Overview
    2. Global Genetic Testing Market, 2016 - 2028 (USD Million)
    3. Global Genetic Testing Market - by Test Type
      1. By Diagnostic Testing
      2. By Predictive and Presymptomatic Testing
      3. By Carrier Testing
      4. By Prenatal and Newborn Screening
      5. By Pharmacogenomic Testing
      6. By Other
    4. Global Genetic Testing Market - by Technology
      1. By Next-Generation Sequencing (NGS)
      2. By Polymerase Chain Reaction (PCR)
      3. By Chromosomal Microarray
      4. By Fluorescence In Situ Hybridization (FISH)
      5. By Sanger Sequencing
    5. Global Genetic Testing Market - by Application
      1. By Oncology
      2. By Rare Diseases
      3. By Neurological Disorders
      4. By Cardiovascular Diseases
      5. By Genetic Disease Risk Assessment
      6. By Ancestry Testing
      7. By Paternity Testing
      8. By Other
    6. Global Genetic Testing Market - by End-User
      1. By Hospitals and Clinics
      2. By Diagnostic Laboratories
      3. By Research Institutes
      4. By Direct-to-Consumer (DTC) Testing Services
      5. By Forensic Laboratories
      6. By Other
    7. Global Genetic Testing Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    8. Market comparative analysis
  4. North America Genetic Testing Market - Segment Analysis
    1. Overview
    2. North America Genetic Testing Market, 2016 - 2028 (USD Million)
    3. North America Genetic Testing Market, by Test Type
      1. By Diagnostic Testing
      2. By Predictive and Presymptomatic Testing
      3. By Carrier Testing
      4. By Prenatal and Newborn Screening
      5. By Pharmacogenomic Testing
      6. By Other
    4. North America Genetic Testing Market, by Technology
      1. By Next-Generation Sequencing (NGS)
      2. By Polymerase Chain Reaction (PCR)
      3. By Chromosomal Microarray
      4. By Fluorescence In Situ Hybridization (FISH)
      5. By Sanger Sequencing
    5. North America Genetic Testing Market, by Application
      1. By Oncology
      2. By Rare Diseases
      3. By Neurological Disorders
      4. By Cardiovascular Diseases
      5. By Genetic Disease Risk Assessment
      6. By Ancestry Testing
      7. By Paternity Testing
      8. By Other
    6. North America Genetic Testing Market, by End-User
      1. By Hospitals and Clinics
      2. By Diagnostic Laboratories
      3. By Research Institutes
      4. By Direct-to-Consumer (DTC) Testing Services
      5. By Forensic Laboratories
      6. By Other
    7. North America Genetic Testing Market, by Country
      1. U.S.
        1. U.S. Genetic Testing Market, By Test Type
          1. By Diagnostic Testing
          2. By Predictive and Presymptomatic Testing
          3. By Carrier Testing
          4. By Prenatal and Newborn Screening
          5. By Pharmacogenomic Testing
          6. By Other
        2. U.S. Genetic Testing Market, By Technology
          1. By Next-Generation Sequencing (NGS)
          2. By Polymerase Chain Reaction (PCR)
          3. By Chromosomal Microarray
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Sanger Sequencing
        3. U.S. Genetic Testing Market, By Application
          1. By Oncology
          2. By Rare Diseases
          3. By Neurological Disorders
          4. By Cardiovascular Diseases
          5. By Genetic Disease Risk Assessment
          6. By Ancestry Testing
          7. By Paternity Testing
          8. By Other
        4. U.S. Genetic Testing Market, By End-User
          1. By Hospitals and Clinics
          2. By Diagnostic Laboratories
          3. By Research Institutes
          4. By Direct-to-Consumer (DTC) Testing Services
          5. By Forensic Laboratories
          6. By Other
      2. Canada
        1. Canada Genetic Testing Market, By Test Type
          1. By Diagnostic Testing
          2. By Predictive and Presymptomatic Testing
          3. By Carrier Testing
          4. By Prenatal and Newborn Screening
          5. By Pharmacogenomic Testing
          6. By Other
        2. Canada Genetic Testing Market, By Technology
          1. By Next-Generation Sequencing (NGS)
          2. By Polymerase Chain Reaction (PCR)
          3. By Chromosomal Microarray
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Sanger Sequencing
        3. Canada Genetic Testing Market, By Application
          1. By Oncology
          2. By Rare Diseases
          3. By Neurological Disorders
          4. By Cardiovascular Diseases
          5. By Genetic Disease Risk Assessment
          6. By Ancestry Testing
          7. By Paternity Testing
          8. By Other
        4. Canada Genetic Testing Market, By End-User
          1. By Hospitals and Clinics
          2. By Diagnostic Laboratories
          3. By Research Institutes
          4. By Direct-to-Consumer (DTC) Testing Services
          5. By Forensic Laboratories
          6. By Other
      3. Mexico
        1. Mexico Genetic Testing Market, By Test Type
          1. By Diagnostic Testing
          2. By Predictive and Presymptomatic Testing
          3. By Carrier Testing
          4. By Prenatal and Newborn Screening
          5. By Pharmacogenomic Testing
          6. By Other
        2. Mexico Genetic Testing Market, By Technology
          1. By Next-Generation Sequencing (NGS)
          2. By Polymerase Chain Reaction (PCR)
          3. By Chromosomal Microarray
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Sanger Sequencing
        3. Mexico Genetic Testing Market, By Application
          1. By Oncology
          2. By Rare Diseases
          3. By Neurological Disorders
          4. By Cardiovascular Diseases
          5. By Genetic Disease Risk Assessment
          6. By Ancestry Testing
          7. By Paternity Testing
          8. By Other
        4. Mexico Genetic Testing Market, By End-User
          1. By Hospitals and Clinics
          2. By Diagnostic Laboratories
          3. By Research Institutes
          4. By Direct-to-Consumer (DTC) Testing Services
          5. By Forensic Laboratories
          6. By Other
  5. Europe Genetic Testing Market - Segment Analysis
    1. Overview
    2. Europe Genetic Testing Market, 2016 - 2028 (USD Million)
    3. Europe Genetic Testing Market, by Test Type
      1. By Diagnostic Testing
      2. By Predictive and Presymptomatic Testing
      3. By Carrier Testing
      4. By Prenatal and Newborn Screening
      5. By Pharmacogenomic Testing
      6. By Other
    4. Europe Genetic Testing Market, by Technology
      1. By Next-Generation Sequencing (NGS)
      2. By Polymerase Chain Reaction (PCR)
      3. By Chromosomal Microarray
      4. By Fluorescence In Situ Hybridization (FISH)
      5. By Sanger Sequencing
    5. Europe Genetic Testing Market, by Application
      1. By Oncology
      2. By Rare Diseases
      3. By Neurological Disorders
      4. By Cardiovascular Diseases
      5. By Genetic Disease Risk Assessment
      6. By Ancestry Testing
      7. By Paternity Testing
      8. By Other
    6. Europe Genetic Testing Market, by End-User
      1. By Hospitals and Clinics
      2. By Diagnostic Laboratories
      3. By Research Institutes
      4. By Direct-to-Consumer (DTC) Testing Services
      5. By Forensic Laboratories
      6. By Other
    7. Europe Genetic Testing Market, by Country
      1. Germany
        1. Germany Genetic Testing Market, By Test Type
          1. By Diagnostic Testing
          2. By Predictive and Presymptomatic Testing
          3. By Carrier Testing
          4. By Prenatal and Newborn Screening
          5. By Pharmacogenomic Testing
          6. By Other
        2. Germany Genetic Testing Market, By Technology
          1. By Next-Generation Sequencing (NGS)
          2. By Polymerase Chain Reaction (PCR)
          3. By Chromosomal Microarray
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Sanger Sequencing
        3. Germany Genetic Testing Market, By Application
          1. By Oncology
          2. By Rare Diseases
          3. By Neurological Disorders
          4. By Cardiovascular Diseases
          5. By Genetic Disease Risk Assessment
          6. By Ancestry Testing
          7. By Paternity Testing
          8. By Other
        4. Germany Genetic Testing Market, By End-User
          1. By Hospitals and Clinics
          2. By Diagnostic Laboratories
          3. By Research Institutes
          4. By Direct-to-Consumer (DTC) Testing Services
          5. By Forensic Laboratories
          6. By Other
      2. UK
        1. UK Market, By Test Type
          1. By Diagnostic Testing
          2. By Predictive and Presymptomatic Testing
          3. By Carrier Testing
          4. By Prenatal and Newborn Screening
          5. By Pharmacogenomic Testing
          6. By Other
        2. UK Market, By Technology
          1. By Next-Generation Sequencing (NGS)
          2. By Polymerase Chain Reaction (PCR)
          3. By Chromosomal Microarray
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Sanger Sequencing
        3. UK Market, By Application
          1. By Oncology
          2. By Rare Diseases
          3. By Neurological Disorders
          4. By Cardiovascular Diseases
          5. By Genetic Disease Risk Assessment
          6. By Ancestry Testing
          7. By Paternity Testing
          8. By Other
        4. UK Market, By End-User
          1. By Hospitals and Clinics
          2. By Diagnostic Laboratories
          3. By Research Institutes
          4. By Direct-to-Consumer (DTC) Testing Services
          5. By Forensic Laboratories
          6. By Other
      3. France
        1. France Genetic Testing Market, By Test Type
          1. By Diagnostic Testing
          2. By Predictive and Presymptomatic Testing
          3. By Carrier Testing
          4. By Prenatal and Newborn Screening
          5. By Pharmacogenomic Testing
          6. By Other
        2. France Genetic Testing Market, By Technology
          1. By Next-Generation Sequencing (NGS)
          2. By Polymerase Chain Reaction (PCR)
          3. By Chromosomal Microarray
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Sanger Sequencing
        3. France Genetic Testing Market, By Application
          1. By Oncology
          2. By Rare Diseases
          3. By Neurological Disorders
          4. By Cardiovascular Diseases
          5. By Genetic Disease Risk Assessment
          6. By Ancestry Testing
          7. By Paternity Testing
          8. By Other
        4. France Genetic Testing Market, By End-User
          1. By Hospitals and Clinics
          2. By Diagnostic Laboratories
          3. By Research Institutes
          4. By Direct-to-Consumer (DTC) Testing Services
          5. By Forensic Laboratories
          6. By Other
      4. Spain
        1. Spain Genetic Testing Market, By Test Type
          1. By Diagnostic Testing
          2. By Predictive and Presymptomatic Testing
          3. By Carrier Testing
          4. By Prenatal and Newborn Screening
          5. By Pharmacogenomic Testing
          6. By Other
        2. Spain Genetic Testing Market, By Technology
          1. By Next-Generation Sequencing (NGS)
          2. By Polymerase Chain Reaction (PCR)
          3. By Chromosomal Microarray
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Sanger Sequencing
        3. Spain Genetic Testing Market, By Application
          1. By Oncology
          2. By Rare Diseases
          3. By Neurological Disorders
          4. By Cardiovascular Diseases
          5. By Genetic Disease Risk Assessment
          6. By Ancestry Testing
          7. By Paternity Testing
          8. By Other
        4. Spain Genetic Testing Market, By End-User
          1. By Hospitals and Clinics
          2. By Diagnostic Laboratories
          3. By Research Institutes
          4. By Direct-to-Consumer (DTC) Testing Services
          5. By Forensic Laboratories
          6. By Other
      5. Italy
        1. Italy Genetic Testing Market, By Test Type
          1. By Diagnostic Testing
          2. By Predictive and Presymptomatic Testing
          3. By Carrier Testing
          4. By Prenatal and Newborn Screening
          5. By Pharmacogenomic Testing
          6. By Other
        2. Italy Genetic Testing Market, By Technology
          1. By Next-Generation Sequencing (NGS)
          2. By Polymerase Chain Reaction (PCR)
          3. By Chromosomal Microarray
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Sanger Sequencing
        3. Italy Genetic Testing Market, By Application
          1. By Oncology
          2. By Rare Diseases
          3. By Neurological Disorders
          4. By Cardiovascular Diseases
          5. By Genetic Disease Risk Assessment
          6. By Ancestry Testing
          7. By Paternity Testing
          8. By Other
        4. Italy Genetic Testing Market, By End-User
          1. By Hospitals and Clinics
          2. By Diagnostic Laboratories
          3. By Research Institutes
          4. By Direct-to-Consumer (DTC) Testing Services
          5. By Forensic Laboratories
          6. By Other
      6. BENELUX
        1. BENELUX Genetic Testing Market, By Test Type
          1. By Diagnostic Testing
          2. By Predictive and Presymptomatic Testing
          3. By Carrier Testing
          4. By Prenatal and Newborn Screening
          5. By Pharmacogenomic Testing
          6. By Other
        2. BENELUX Genetic Testing Market, By Technology
          1. By Next-Generation Sequencing (NGS)
          2. By Polymerase Chain Reaction (PCR)
          3. By Chromosomal Microarray
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Sanger Sequencing
        3. BENELUX Genetic Testing Market, By Application
          1. By Oncology
          2. By Rare Diseases
          3. By Neurological Disorders
          4. By Cardiovascular Diseases
          5. By Genetic Disease Risk Assessment
          6. By Ancestry Testing
          7. By Paternity Testing
          8. By Other
        4. BENELUX Genetic Testing Market, By End-User
          1. By Hospitals and Clinics
          2. By Diagnostic Laboratories
          3. By Research Institutes
          4. By Direct-to-Consumer (DTC) Testing Services
          5. By Forensic Laboratories
          6. By Other
      7. Rest of Europe
        1. Rest Of Europe Genetic Testing Market, By Test Type
          1. By Diagnostic Testing
          2. By Predictive and Presymptomatic Testing
          3. By Carrier Testing
          4. By Prenatal and Newborn Screening
          5. By Pharmacogenomic Testing
          6. By Other
        2. Rest Of Europe Genetic Testing Market, By Technology
          1. By Next-Generation Sequencing (NGS)
          2. By Polymerase Chain Reaction (PCR)
          3. By Chromosomal Microarray
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Sanger Sequencing
        3. Rest Of Europe Genetic Testing Market, By Application
          1. By Oncology
          2. By Rare Diseases
          3. By Neurological Disorders
          4. By Cardiovascular Diseases
          5. By Genetic Disease Risk Assessment
          6. By Ancestry Testing
          7. By Paternity Testing
          8. By Other
        4. Rest Of Europe Genetic Testing Market, By End-User
          1. By Hospitals and Clinics
          2. By Diagnostic Laboratories
          3. By Research Institutes
          4. By Direct-to-Consumer (DTC) Testing Services
          5. By Forensic Laboratories
          6. By Other
  6. Asia Pacific Genetic Testing Market - Segment Analysis
    1. Overview
    2. Asia Pacific Genetic Testing Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Genetic Testing Market, by Test Type
      1. By Diagnostic Testing
      2. By Predictive and Presymptomatic Testing
      3. By Carrier Testing
      4. By Prenatal and Newborn Screening
      5. By Pharmacogenomic Testing
      6. By Other
    4. Asia Pacific Genetic Testing Market, by Technology
      1. By Next-Generation Sequencing (NGS)
      2. By Polymerase Chain Reaction (PCR)
      3. By Chromosomal Microarray
      4. By Fluorescence In Situ Hybridization (FISH)
      5. By Sanger Sequencing
    5. Asia Pacific Genetic Testing Market, by Application
      1. By Oncology
      2. By Rare Diseases
      3. By Neurological Disorders
      4. By Cardiovascular Diseases
      5. By Genetic Disease Risk Assessment
      6. By Ancestry Testing
      7. By Paternity Testing
      8. By Other
    6. Asia Pacific Genetic Testing Market, by End-User
      1. By Hospitals and Clinics
      2. By Diagnostic Laboratories
      3. By Research Institutes
      4. By Direct-to-Consumer (DTC) Testing Services
      5. By Forensic Laboratories
      6. By Other
    7. Asia Pacific Genetic Testing Market, by Country
      1. China
        1. China Genetic Testing Market, By Test Type
          1. By Diagnostic Testing
          2. By Predictive and Presymptomatic Testing
          3. By Carrier Testing
          4. By Prenatal and Newborn Screening
          5. By Pharmacogenomic Testing
          6. By Other
        2. China Genetic Testing Market, By Technology
          1. By Next-Generation Sequencing (NGS)
          2. By Polymerase Chain Reaction (PCR)
          3. By Chromosomal Microarray
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Sanger Sequencing
        3. China Genetic Testing Market, By Application
          1. By Oncology
          2. By Rare Diseases
          3. By Neurological Disorders
          4. By Cardiovascular Diseases
          5. By Genetic Disease Risk Assessment
          6. By Ancestry Testing
          7. By Paternity Testing
          8. By Other
        4. China Genetic Testing Market, By End-User
          1. By Hospitals and Clinics
          2. By Diagnostic Laboratories
          3. By Research Institutes
          4. By Direct-to-Consumer (DTC) Testing Services
          5. By Forensic Laboratories
          6. By Other
      2. Japan
        1. Japan Genetic Testing Market, By Test Type
          1. By Diagnostic Testing
          2. By Predictive and Presymptomatic Testing
          3. By Carrier Testing
          4. By Prenatal and Newborn Screening
          5. By Pharmacogenomic Testing
          6. By Other
        2. Japan Genetic Testing Market, By Technology
          1. By Next-Generation Sequencing (NGS)
          2. By Polymerase Chain Reaction (PCR)
          3. By Chromosomal Microarray
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Sanger Sequencing
        3. Japan Genetic Testing Market, By Application
          1. By Oncology
          2. By Rare Diseases
          3. By Neurological Disorders
          4. By Cardiovascular Diseases
          5. By Genetic Disease Risk Assessment
          6. By Ancestry Testing
          7. By Paternity Testing
          8. By Other
        4. Japan Genetic Testing Market, By End-User
          1. By Hospitals and Clinics
          2. By Diagnostic Laboratories
          3. By Research Institutes
          4. By Direct-to-Consumer (DTC) Testing Services
          5. By Forensic Laboratories
          6. By Other
      3. India
        1. India Genetic Testing Market, By Test Type
          1. By Diagnostic Testing
          2. By Predictive and Presymptomatic Testing
          3. By Carrier Testing
          4. By Prenatal and Newborn Screening
          5. By Pharmacogenomic Testing
          6. By Other
        2. India Genetic Testing Market, By Technology
          1. By Next-Generation Sequencing (NGS)
          2. By Polymerase Chain Reaction (PCR)
          3. By Chromosomal Microarray
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Sanger Sequencing
        3. India Genetic Testing Market, By Application
          1. By Oncology
          2. By Rare Diseases
          3. By Neurological Disorders
          4. By Cardiovascular Diseases
          5. By Genetic Disease Risk Assessment
          6. By Ancestry Testing
          7. By Paternity Testing
          8. By Other
        4. India Genetic Testing Market, By End-User
          1. By Hospitals and Clinics
          2. By Diagnostic Laboratories
          3. By Research Institutes
          4. By Direct-to-Consumer (DTC) Testing Services
          5. By Forensic Laboratories
          6. By Other
      4. South Korea
        1. South Korea Genetic Testing Market, By Test Type
          1. By Diagnostic Testing
          2. By Predictive and Presymptomatic Testing
          3. By Carrier Testing
          4. By Prenatal and Newborn Screening
          5. By Pharmacogenomic Testing
          6. By Other
        2. South Korea Genetic Testing Market, By Technology
          1. By Next-Generation Sequencing (NGS)
          2. By Polymerase Chain Reaction (PCR)
          3. By Chromosomal Microarray
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Sanger Sequencing
        3. South Korea Genetic Testing Market, By Application
          1. By Oncology
          2. By Rare Diseases
          3. By Neurological Disorders
          4. By Cardiovascular Diseases
          5. By Genetic Disease Risk Assessment
          6. By Ancestry Testing
          7. By Paternity Testing
          8. By Other
        4. South Korea Genetic Testing Market, By End-User
          1. By Hospitals and Clinics
          2. By Diagnostic Laboratories
          3. By Research Institutes
          4. By Direct-to-Consumer (DTC) Testing Services
          5. By Forensic Laboratories
          6. By Other
      5. South East Asia
        1. South East Asia Genetic Testing Market, By Test Type
          1. By Diagnostic Testing
          2. By Predictive and Presymptomatic Testing
          3. By Carrier Testing
          4. By Prenatal and Newborn Screening
          5. By Pharmacogenomic Testing
          6. By Other
        2. South East Asia Genetic Testing Market, By Technology
          1. By Next-Generation Sequencing (NGS)
          2. By Polymerase Chain Reaction (PCR)
          3. By Chromosomal Microarray
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Sanger Sequencing
        3. South East Asia Genetic Testing Market, By Application
          1. By Oncology
          2. By Rare Diseases
          3. By Neurological Disorders
          4. By Cardiovascular Diseases
          5. By Genetic Disease Risk Assessment
          6. By Ancestry Testing
          7. By Paternity Testing
          8. By Other
        4. South East Asia Genetic Testing Market, By End-User
          1. By Hospitals and Clinics
          2. By Diagnostic Laboratories
          3. By Research Institutes
          4. By Direct-to-Consumer (DTC) Testing Services
          5. By Forensic Laboratories
          6. By Other
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Genetic Testing Market, By Test Type
          1. By Diagnostic Testing
          2. By Predictive and Presymptomatic Testing
          3. By Carrier Testing
          4. By Prenatal and Newborn Screening
          5. By Pharmacogenomic Testing
          6. By Other
        2. Rest of Asia Pacific Genetic Testing Market, By Technology
          1. By Next-Generation Sequencing (NGS)
          2. By Polymerase Chain Reaction (PCR)
          3. By Chromosomal Microarray
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Sanger Sequencing
        3. Rest of Asia Pacific Genetic Testing Market, By Application
          1. By Oncology
          2. By Rare Diseases
          3. By Neurological Disorders
          4. By Cardiovascular Diseases
          5. By Genetic Disease Risk Assessment
          6. By Ancestry Testing
          7. By Paternity Testing
          8. By Other
        4. Rest of Asia Pacific Genetic Testing Market, By End-User
          1. By Hospitals and Clinics
          2. By Diagnostic Laboratories
          3. By Research Institutes
          4. By Direct-to-Consumer (DTC) Testing Services
          5. By Forensic Laboratories
          6. By Other
  7. Latin America Genetic Testing Market - Segment Analysis
    1. Overview
    2. Latin America Genetic Testing Market, 2016 - 2028 (USD Million)
    3. Latin America Genetic Testing Market, by Test Type
      1. By Diagnostic Testing
      2. By Predictive and Presymptomatic Testing
      3. By Carrier Testing
      4. By Prenatal and Newborn Screening
      5. By Pharmacogenomic Testing
      6. By Other
    4. Latin America Genetic Testing Market, by Technology
      1. By Next-Generation Sequencing (NGS)
      2. By Polymerase Chain Reaction (PCR)
      3. By Chromosomal Microarray
      4. By Fluorescence In Situ Hybridization (FISH)
      5. By Sanger Sequencing
    5. Latin America Genetic Testing Market, by Application
      1. By Oncology
      2. By Rare Diseases
      3. By Neurological Disorders
      4. By Cardiovascular Diseases
      5. By Genetic Disease Risk Assessment
      6. By Ancestry Testing
      7. By Paternity Testing
      8. By Other
    6. Latin America Genetic Testing Market, by End-User
      1. By Hospitals and Clinics
      2. By Diagnostic Laboratories
      3. By Research Institutes
      4. By Direct-to-Consumer (DTC) Testing Services
      5. By Forensic Laboratories
      6. By Other
    7. Latin America Genetic Testing Market, by Country
      1. Brazil
        1. Brazil Genetic Testing Market, By Test Type
          1. By Diagnostic Testing
          2. By Predictive and Presymptomatic Testing
          3. By Carrier Testing
          4. By Prenatal and Newborn Screening
          5. By Pharmacogenomic Testing
          6. By Other
        2. Brazil Genetic Testing Market, By Technology
          1. By Next-Generation Sequencing (NGS)
          2. By Polymerase Chain Reaction (PCR)
          3. By Chromosomal Microarray
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Sanger Sequencing
        3. Brazil Genetic Testing Market, By Application
          1. By Oncology
          2. By Rare Diseases
          3. By Neurological Disorders
          4. By Cardiovascular Diseases
          5. By Genetic Disease Risk Assessment
          6. By Ancestry Testing
          7. By Paternity Testing
          8. By Other
        4. Brazil Genetic Testing Market, By End-User
          1. By Hospitals and Clinics
          2. By Diagnostic Laboratories
          3. By Research Institutes
          4. By Direct-to-Consumer (DTC) Testing Services
          5. By Forensic Laboratories
          6. By Other
      2. Argentina
        1. Argentina Genetic Testing Market, By Test Type
          1. By Diagnostic Testing
          2. By Predictive and Presymptomatic Testing
          3. By Carrier Testing
          4. By Prenatal and Newborn Screening
          5. By Pharmacogenomic Testing
          6. By Other
        2. Argentina Genetic Testing Market, By Technology
          1. By Next-Generation Sequencing (NGS)
          2. By Polymerase Chain Reaction (PCR)
          3. By Chromosomal Microarray
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Sanger Sequencing
        3. Argentina Genetic Testing Market, By Application
          1. By Oncology
          2. By Rare Diseases
          3. By Neurological Disorders
          4. By Cardiovascular Diseases
          5. By Genetic Disease Risk Assessment
          6. By Ancestry Testing
          7. By Paternity Testing
          8. By Other
        4. Argentina Genetic Testing Market, By End-User
          1. By Hospitals and Clinics
          2. By Diagnostic Laboratories
          3. By Research Institutes
          4. By Direct-to-Consumer (DTC) Testing Services
          5. By Forensic Laboratories
          6. By Other
      3. Rest of Latin America
        1. Rest of Latin America Genetic Testing Market, By Test Type
          1. By Diagnostic Testing
          2. By Predictive and Presymptomatic Testing
          3. By Carrier Testing
          4. By Prenatal and Newborn Screening
          5. By Pharmacogenomic Testing
          6. By Other
        2. Rest of Latin America Genetic Testing Market, By Technology
          1. By Next-Generation Sequencing (NGS)
          2. By Polymerase Chain Reaction (PCR)
          3. By Chromosomal Microarray
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Sanger Sequencing
        3. Rest of Latin America Genetic Testing Market, By Application
          1. By Oncology
          2. By Rare Diseases
          3. By Neurological Disorders
          4. By Cardiovascular Diseases
          5. By Genetic Disease Risk Assessment
          6. By Ancestry Testing
          7. By Paternity Testing
          8. By Other
        4. Rest of Latin America Genetic Testing Market, By End-User
          1. By Hospitals and Clinics
          2. By Diagnostic Laboratories
          3. By Research Institutes
          4. By Direct-to-Consumer (DTC) Testing Services
          5. By Forensic Laboratories
          6. By Other
  8. Middle East & Africa Genetic Testing Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Genetic Testing Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Genetic Testing Market, by Test Type
      1. By Diagnostic Testing
      2. By Predictive and Presymptomatic Testing
      3. By Carrier Testing
      4. By Prenatal and Newborn Screening
      5. By Pharmacogenomic Testing
      6. By Other
    4. Middle East & Africa Genetic Testing Market, by Technology
      1. By Next-Generation Sequencing (NGS)
      2. By Polymerase Chain Reaction (PCR)
      3. By Chromosomal Microarray
      4. By Fluorescence In Situ Hybridization (FISH)
      5. By Sanger Sequencing
    5. Middle East & Africa Genetic Testing Market, by Application
      1. By Oncology
      2. By Rare Diseases
      3. By Neurological Disorders
      4. By Cardiovascular Diseases
      5. By Genetic Disease Risk Assessment
      6. By Ancestry Testing
      7. By Paternity Testing
      8. By Other
    6. Middle East & Africa Genetic Testing Market, by End-User
      1. By Hospitals and Clinics
      2. By Diagnostic Laboratories
      3. By Research Institutes
      4. By Direct-to-Consumer (DTC) Testing Services
      5. By Forensic Laboratories
      6. By Other
    7. Middle East & Africa Genetic Testing Market, by Country
      1. GCC Countries
        1. GCC Countries Genetic Testing Market, By Test Type
          1. By Diagnostic Testing
          2. By Predictive and Presymptomatic Testing
          3. By Carrier Testing
          4. By Prenatal and Newborn Screening
          5. By Pharmacogenomic Testing
          6. By Other
        2. GCC Countries Genetic Testing Market, By Technology
          1. By Next-Generation Sequencing (NGS)
          2. By Polymerase Chain Reaction (PCR)
          3. By Chromosomal Microarray
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Sanger Sequencing
        3. GCC Countries Genetic Testing Market, By Application
          1. By Oncology
          2. By Rare Diseases
          3. By Neurological Disorders
          4. By Cardiovascular Diseases
          5. By Genetic Disease Risk Assessment
          6. By Ancestry Testing
          7. By Paternity Testing
          8. By Other
        4. GCC Countries Genetic Testing Market, By End-User
          1. By Hospitals and Clinics
          2. By Diagnostic Laboratories
          3. By Research Institutes
          4. By Direct-to-Consumer (DTC) Testing Services
          5. By Forensic Laboratories
          6. By Other
      2. South Africa
        1. South Africa Genetic Testing Market, By Test Type
          1. By Diagnostic Testing
          2. By Predictive and Presymptomatic Testing
          3. By Carrier Testing
          4. By Prenatal and Newborn Screening
          5. By Pharmacogenomic Testing
          6. By Other
        2. South Africa Genetic Testing Market, By Technology
          1. By Next-Generation Sequencing (NGS)
          2. By Polymerase Chain Reaction (PCR)
          3. By Chromosomal Microarray
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Sanger Sequencing
        3. South Africa Genetic Testing Market, By Application
          1. By Oncology
          2. By Rare Diseases
          3. By Neurological Disorders
          4. By Cardiovascular Diseases
          5. By Genetic Disease Risk Assessment
          6. By Ancestry Testing
          7. By Paternity Testing
          8. By Other
        4. South Africa Genetic Testing Market, By End-User
          1. By Hospitals and Clinics
          2. By Diagnostic Laboratories
          3. By Research Institutes
          4. By Direct-to-Consumer (DTC) Testing Services
          5. By Forensic Laboratories
          6. By Other
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Genetic Testing Market, By Test Type
          1. By Diagnostic Testing
          2. By Predictive and Presymptomatic Testing
          3. By Carrier Testing
          4. By Prenatal and Newborn Screening
          5. By Pharmacogenomic Testing
          6. By Other
        2. Rest of Middle East & Africa Genetic Testing Market, By Technology
          1. By Next-Generation Sequencing (NGS)
          2. By Polymerase Chain Reaction (PCR)
          3. By Chromosomal Microarray
          4. By Fluorescence In Situ Hybridization (FISH)
          5. By Sanger Sequencing
        3. Rest of Middle East & Africa Genetic Testing Market, By Application
          1. By Oncology
          2. By Rare Diseases
          3. By Neurological Disorders
          4. By Cardiovascular Diseases
          5. By Genetic Disease Risk Assessment
          6. By Ancestry Testing
          7. By Paternity Testing
          8. By Other
        4. Rest of Middle East & Africa Genetic Testing Market, By End-User
          1. By Hospitals and Clinics
          2. By Diagnostic Laboratories
          3. By Research Institutes
          4. By Direct-to-Consumer (DTC) Testing Services
          5. By Forensic Laboratories
          6. By Other
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Abbott Laboratories
    2. Danaher Corporation (Cepheid Inc.)
    3. Illumina Inc.
    4. BioRad Laboratories Inc.
    5. F. Hoffmann-La Roche Ltd
    6. 23andMe Inc.
    7. Myriad Genetics Inc.
    8. DiaSorin S.p.A. (Luminex Corporation)
    9. PerkinElmer Inc.
    10. Quest Diagnostics Incorporated
    11. Eurofins Scientific
    12. Qiagen N.V.
    13. Thermo Fisher Scientific
    14. Invitae Corporation
    15. Agilent Technologies.
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
Vantage Market Research | 06-Nov-2024
Genetic Testing Market Size to Reach USD 65.91 Bn by 2034
FAQ
Frequently Asked Question

  • The global Genetic Testing valued at USD 22.60 Billion in 2024 and is expected to reach USD 65.91 Billion in 2034 growing at a CAGR of 11.3%.

  • The prominent players in the market are Abbott Laboratories, Danaher Corporation (Cepheid Inc.), Illumina Inc., BioRad Laboratories Inc., F. Hoffmann-La Roche Ltd, 23andMe Inc., Myriad Genetics Inc., DiaSorin S.p.A. (Luminex Corporation), PerkinElmer Inc., Quest Diagnostics Incorporated, Eurofins Scientific, Qiagen N.V., Thermo Fisher Scientific, Invitae Corporation, Agilent Technologies..

  • The market is project to grow at a CAGR of 11.3% between 2025 and 2034.

  • The driving factors of the Genetic Testing include

  • North America was the leading regional segment of the Genetic Testing in 2024.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy